Outcomes of Patients Intended for Autologous Stem Cell Transplantation with CT-Based Partial Response but PET-Based Deauville Score of 5 after Salvage Chemotherapy
Sign Up to like & getrecommendations! Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-201150
Abstract: Background: Salvage chemotherapy (ST) followed by autologous stem cell transplant (ASCT) is widely used to treat relapsed/refractory large B-cell lymphomas (LBCL), both for late relapses and in jurisdictions without access to second-line chimeric antigen receptor… read more here.
Keywords: asct; car; cell; pet ... See more keywords
Predictive Value of Clonal Plasma Cells in Autografts Assessed By Next Generation Flow Cytometry on Pre-Transplant Bone Marrow MRD in Multiple Myeloma Patients
Sign Up to like & getrecommendations! Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-204692
Abstract: Background: High-dose melphalan followed by autologous stem cell transplantation (ASCT) represents the standard of care for multiple myeloma (MM) patients. However, the clinical significance of minimal residual disease (MRD) in hematopoietic cell grafts (gMRD) remains… read more here.
Keywords: pre asct; gmrd; asct mrd; asct ... See more keywords
Predictive Power of Early, Sequential Minimal Residual Disease and Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography Monitoring in Young Patients with Mantle Cell Lymphoma in the Lyma Trial: A Lysa Study
Sign Up to like & getrecommendations! Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-208081
Abstract: PURPOSE Minimal residual disease (MRD) can predict outcomes in patients with mantle cell lymphoma (MCL) but data are limited for younger patients undergoing ASCT (autologous-stem-cell-transplantation) and rituximab maintenance (RM) and no data are available on… read more here.
Keywords: pfs; mrd; post asct; pet ... See more keywords